Clinical & Diagnostic
Simcere Zaiming and AbbVie Partner to Advance Novel Trispecific Antibody for Multiple Myeloma Treatment
Simcere Zaiming, a subsidiary of Simcere Pharmaceutical Group Ltd (HKEX: 2096) and AbbVie Inc. (NYSE: ABBV) today announced an option to license agreement ...
January 14, 2025 | News
JW Therapeutics' Carteyva® Secures Breakthrough Therapy Designation in China for Relapsed/Refractory Large B-Cell Lymphoma
W Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focused on developing, manufacturing and commercializing ce...
January 13, 2025 | News
Menarini Group Partners with Insilico Medicine on AI-Discovered Oncology Asset in $550M Licensing Deal
This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform, si...
January 13, 2025 | News
Samsung Biologics and LigaChem Biosciences Partner to Advance ADC Therapies with New Dedicated Facility
Samsung Biologics to offer ADC services at new dedicated facility Extended collaboration reflects successful partnership and expertise Samsung Biolog...
January 09, 2025 | News
Genomics England Partners with QIAGEN to Deliver Pioneering Whole-Genome Sequencing Study for Newborns
Genomics England select QIAGEN’s Clinical Knowledge Base to power first-of-its-kind whole-genome sequencing study for newborns National stud...
January 08, 2025 | News
I-Mab Prioritizes Lead Program Givastomig to Advance Precision Immuno-Oncology for Gastric Cancer
Givastomig: a Claudin 18.2 ("CLDN18.2") x 4-1BB bispecific antibody, will be the lead clinical program following the Company's portfolio prioritization ...
January 07, 2025 | News
NUS Researchers Harness Magnetic Pulses to Enhance Chemotherapy Effectiveness
A recent study explained the mechanisms by which pulsed electromagnetic field therapy enhances doxorubicin uptake, paving the way for precision-driven canc...
January 07, 2025 | News
Human Metapneumovirus Sparks Concern Across Asia: India Joins Global Vigilance
The detection of Human Metapneumovirus (HMPV) in Karnataka, India, and a rising number of cases across Asia have prompted heightened vigilance among health...
January 06, 2025 | Analysis
European Commission Approves Amivantamab Plus Lazertinib for First-Line Treatment of EGFR-Mutated NSCLC
Janssen-Cilag International NV, a Johnson & Johnson company,announced the European Commission (EC) approval for a Type II variation indication extensio...
January 03, 2025 | News
Verastem Oncology’s NDA for Avutometinib-Defactinib Combo in KRAS Mutant LGSOC Accepted by FDA with Priority Review
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, announced that the U.S. Food a...
January 02, 2025 | News
Alphamab Oncology Gains Approval for Phase III Clinical Study of Anti-HER2 ADC JSKN003 in Platinum-Resistant Ovarian Cancer
Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 has received approval from the Center for...
December 30, 2024 | News
Shanghai Matwings Secures Series A Funding to Advance AI-Driven Protein Design with AccelProtein™
Shanghai Matwings Technology Co., Ltd. ('Matwings'), a global leader in AI-driven protein design, announced the successful completion of Series A funding r...
December 26, 2024 | News
Keymed Biosciences Secures NMPA Approval for Stapokibart to Treat Chronic Rhinosinusitis with Nasal Polyposis
Keymed Biosciences Inc. announced the National Medical Products Administration (the "NMPA") of China has recently approved the supplemental New D...
December 24, 2024 | News
Innovent Biologics Secures NMPA Approval for DOVBLERON®, a Next-Generation Precision Therapy for ROS1-Positive NSCLC
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
December 23, 2024 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
